CVS Health Corporation/ US1266501006 /
2024-10-31 9:10:00 PM | Chg. +0.07 | Volume | Bid11:45:18 PM | Ask11:45:18 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
56.46USD | +0.12% | 7.56 mill. Turnover: 326.27 mill. |
56.37Bid Size: 100 | 56.46Ask Size: 600 | 71.03 bill.USD | 4.29% | 8.70 |
Assets
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 10,175 | 10,292 | 11,349 | 12,044 | 12,606 | ||||||
Intangible Assets | 13,511 | 13,630 | 36,524 | 33,121 | 31,142 | ||||||
Long-Term Investments | - | - | 15,732 | 17,314 | 20,812 | ||||||
Fixed Assets | 63,420 | 63,902 | 151,213 | 172,147 | 174,346 | ||||||
Inventories | 14,760 | 15,296 | 16,450 | 17,516 | 18,496 | ||||||
Accounts Receivable | 12,164 | 13,181 | 17,631 | 19,617 | 21,742 | ||||||
Cash and Cash Equivalents | 3,371 | 1,696 | 4,059 | 5,683 | 7,854 | ||||||
Current Assets | 31,042 | 31,229 | 45,243 | 50,302 | 56,369 | ||||||
Total Assets | 94,462 | 95,131 | 196,456 | 222,449 | 230,715 |
Liabilities
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 7,946 | 8,863 | 8,925 | 10,492 | 11,138 | ||||||
Long-term debt | 25,615 | 22,181 | 71,444 | 64,699 | 59,207 | ||||||
Liabilities to Banks | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Provisions | 4,214 | 2,996 | 7,677 | 7,294 | 6,794 | ||||||
Liabilities | 57,628 | 57,436 | 137,913 | 158,279 | 161,014 | ||||||
Share Capital | - | - | - | - | - | ||||||
Total Equity | 36,834 | 37,695 | 58,543 | 64,170 | 69,701 | ||||||
Minority Interests | 4 | 4 | 318 | 306 | 312 | ||||||
Total liabilities equity | 94,462 | 95,131 | 196,456 | 222,449 | 230,715 |
Income Statement
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 177,526 | 184,765 | 194,579 | 256,776 | 268,706 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | 10,338 | 9,517 | 4,021 | 11,987 | 13,911 | ||||||
Interest Income | 1,058 | 1,041 | 2,619 | 3,035 | 2,907 | ||||||
Income Before Taxes | 8,637 | 8,268 | 1,406 | 8,997 | 9,770 | ||||||
Income Taxes | 3,317 | 1,637 | 2,002 | 2,366 | 2,569 | ||||||
Minority Interests Profit | -2 | -1 | 2 | 3 | -13 | ||||||
Net Income | 5,317 | 6,622 | -594 | 6,634 | 7,179 |
Per Share
Cash Flow
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 10,069 | 8,007 | 8,865 | 12,848 | 15,865 | ||||||
Cash Flow from Investing Activities | -2,470 | -2,932 | -43,285 | -3,339 | -5,534 | ||||||
Cash Flow from Financing | -6,689 | -6,751 | 36,819 | -7,850 | -8,155 | ||||||
Decrease / Increase in Cash | 912 | -1,675 | 2,395 | 1,659 | 2,176 | ||||||
Employees | 250,000 | 246,000 | 295,000 | 290,000 | 300,000 |